• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 CIII 过表达小鼠易患饮食诱导的肝脂肪变性和肝胰岛素抵抗。

Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.

机构信息

Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06536-8012, USA.

出版信息

Hepatology. 2011 Nov;54(5):1650-60. doi: 10.1002/hep.24571. Epub 2011 Aug 19.

DOI:10.1002/hep.24571
PMID:21793029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3205235/
Abstract

UNLABELLED

Nonalcoholic fatty liver disease (NAFLD) and insulin resistance have recently been found to be associated with increased plasma concentrations of apolipoprotein CIII (APOC3) in humans carrying single nucleotide polymorphisms within the insulin response element of the APOC3 gene. To examine whether increased expression of APOC3 would predispose mice to NAFLD and hepatic insulin resistance, human APOC3 overexpressing (ApoC3Tg) mice were metabolically phenotyped following either a regular chow or high-fat diet (HFD). After HFD feeding, ApoC3Tg mice had increased hepatic triglyceride accumulation, which was associated with cellular ballooning and inflammatory changes. ApoC3Tg mice also manifested severe hepatic insulin resistance assessed by a hyperinsulinemic-euglycemic clamp, which could mostly be attributed to increased hepatic diacylglycerol content, protein kinase C-ϵ activation, and decreased insulin-stimulated Akt2 activity. Increased hepatic triglyceride content in the HFD-fed ApoC3Tg mice could be attributed to a ≈ 70% increase in hepatic triglyceride uptake and ≈ 50% reduction hepatic triglyceride secretion.

CONCLUSION

These data demonstrate that increase plasma APOC3 concentrations predispose mice to diet-induced NAFLD and hepatic insulin resistance.

摘要

目的

非酒精性脂肪性肝病(NAFLD)和胰岛素抵抗最近被发现与携带载脂蛋白 CIII(APOC3)基因胰岛素反应元件内单核苷酸多态性的人类血浆中载脂蛋白 CIII(APOC3)浓度升高有关。为了研究 APOC3 表达增加是否会使小鼠易患 NAFLD 和肝胰岛素抵抗,在给予常规饮食或高脂肪饮食(HFD)后,对载脂蛋白 CIII 过表达(ApoC3Tg)小鼠进行了代谢表型分析。在 HFD 喂养后,ApoC3Tg 小鼠肝甘油三酯蓄积增加,这与细胞气球样变和炎症改变有关。通过高胰岛素-正常血糖钳夹术评估,ApoC3Tg 小鼠还表现出严重的肝胰岛素抵抗,这主要归因于肝二酰甘油含量增加、蛋白激酶 C-ε 激活和胰岛素刺激的 Akt2 活性降低。在 HFD 喂养的 ApoC3Tg 小鼠中,肝甘油三酯含量的增加可归因于肝甘油三酯摄取增加约 70%,肝甘油三酯分泌减少约 50%。

结论

这些数据表明,血浆 APOC3 浓度升高使小鼠易患饮食诱导的 NAFLD 和肝胰岛素抵抗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/3977241155eb/hep0054-1650-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/0d391b34116a/hep0054-1650-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/72ba9b0e14f9/hep0054-1650-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/b1850925c98e/hep0054-1650-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/c59a8256f548/hep0054-1650-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/b0b7cf4b5959/hep0054-1650-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/3977241155eb/hep0054-1650-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/0d391b34116a/hep0054-1650-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/72ba9b0e14f9/hep0054-1650-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/b1850925c98e/hep0054-1650-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/c59a8256f548/hep0054-1650-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/b0b7cf4b5959/hep0054-1650-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db35/3500672/3977241155eb/hep0054-1650-f6.jpg

相似文献

1
Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.载脂蛋白 CIII 过表达小鼠易患饮食诱导的肝脂肪变性和肝胰岛素抵抗。
Hepatology. 2011 Nov;54(5):1650-60. doi: 10.1002/hep.24571. Epub 2011 Aug 19.
2
APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.载脂蛋白C3蛋白并非小鼠脂肪诱导的非酒精性脂肪性肝病的诱发因素。
J Biol Chem. 2017 Mar 3;292(9):3692-3705. doi: 10.1074/jbc.M116.765917. Epub 2017 Jan 23.
3
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.载脂蛋白 C3 基因变异与非酒精性脂肪性肝病。
N Engl J Med. 2010 Mar 25;362(12):1082-9. doi: 10.1056/NEJMoa0907295.
4
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.内脏肥胖调节载脂蛋白 C3 基因变异对肝脂肪含量的影响。
Int J Obes (Lond). 2012 Jun;36(6):774-82. doi: 10.1038/ijo.2011.154. Epub 2011 Aug 9.
5
Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.针对β-连环蛋白的第二代反义寡核苷酸可保护小鼠免受饮食诱导的肝脂肪变性以及肝脏和外周胰岛素抵抗。
FASEB J. 2016 Mar;30(3):1207-17. doi: 10.1096/fj.15-271999. Epub 2015 Dec 7.
6
Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice.载脂蛋白 A-I 可调节与饮食诱导的非酒精性脂肪肝疾病相关的过程。
Mol Med. 2012 Sep 7;18(1):901-12. doi: 10.2119/molmed.2012.00113.
7
Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice.细微的代谢和肝脏基因转录变化是胰岛素抵抗小鼠饮食诱导性脂肪肝易感性的基础。
Diabetologia. 2007 Sep;50(9):1867-1879. doi: 10.1007/s00125-007-0738-5. Epub 2007 Jul 6.
8
Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.载脂蛋白 C3 基因变异对非酒精性脂肪性肝病患者肝脏脂肪无影响,而 patatin 样磷脂酶 3 基因变异有影响。
J Gastroenterol Hepatol. 2012 May;27(5):951-6. doi: 10.1111/j.1440-1746.2011.07045.x.
9
Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.载脂蛋白 C3 变异体与肝内甘油三酯含量和胰岛素抵抗的分离。
Hepatology. 2011 Feb;53(2):467-74. doi: 10.1002/hep.24072. Epub 2010 Dec 10.
10
FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet.FoxO6 介导的 ApoC3 上调促进高脂饮食喂养的老年大鼠肝脂肪变性和血脂异常。
Aging (Albany NY). 2024 Mar 3;16(5):4095-4115. doi: 10.18632/aging.205610.

引用本文的文献

1
Mild Mitochondrial Uncoupling for True Ectopic Lipid Disposal.轻度线粒体解偶联用于真正的异位脂质处理。
Int J Mol Sci. 2025 Aug 11;26(16):7740. doi: 10.3390/ijms26167740.
2
Associations Between APOC3 and ANGPTL8 Gene Polymorphisms With MASLD Risk and the Mediation Effect of Triglyceride on MASLD in the Chinese Population.中国人群中APOC3和ANGPTL8基因多态性与代谢相关脂肪性肝病(MASLD)风险的关联及甘油三酯对MASLD的中介作用
J Cell Mol Med. 2025 Apr;29(7):e70542. doi: 10.1111/jcmm.70542.
3
APOC3 as a potential prognostic factor for hepatitis B virus-related acute-on-chronic liver failure.

本文引用的文献

1
Apolipoprotein CIII: 42 years old and even more interesting.载脂蛋白CIII:42岁,甚至更具吸引力。
Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):471-3. doi: 10.1161/ATVBAHA.110.221846.
2
Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance.靶向表达过氧化氢酶到线粒体可预防与年龄相关的线粒体功能下降和胰岛素抵抗。
Cell Metab. 2010 Dec 1;12(6):668-74. doi: 10.1016/j.cmet.2010.11.004.
3
Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men.
载脂蛋白C3作为乙型肝炎病毒相关慢加急性肝衰竭的潜在预后因素。
Medicine (Baltimore). 2025 Feb 7;104(6):e41503. doi: 10.1097/MD.0000000000041503.
4
Insulin Resistance, Obesity, and Lipotoxicity.胰岛素抵抗、肥胖和脂毒性。
Adv Exp Med Biol. 2024;1460:391-430. doi: 10.1007/978-3-031-63657-8_14.
5
Targeting Apolipoprotein C-III for the Management of Severe Hypertriglyceridemia: Current Research and Future Directions.靶向载脂蛋白C-III治疗重度高甘油三酯血症:当前研究与未来方向
Cureus. 2024 Aug 17;16(8):e67091. doi: 10.7759/cureus.67091. eCollection 2024 Aug.
6
Lipopolysaccharide binding protein resists hepatic oxidative stress by regulating lipid droplet homeostasis.脂多糖结合蛋白通过调节脂滴稳态来抵抗肝氧化应激。
Nat Commun. 2024 Apr 13;15(1):3213. doi: 10.1038/s41467-024-47553-5.
7
Graphislactone A, a Fungal Antioxidant Metabolite, Reduces Lipogenesis and Protects against Diet-Induced Hepatic Steatosis in Mice.Graphislactone A,一种真菌抗氧化代谢产物,可减少脂肪生成并预防小鼠饮食诱导的肝脂肪变性。
Int J Mol Sci. 2024 Jan 16;25(2):1096. doi: 10.3390/ijms25021096.
8
Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus.肠道微生物群与胰岛素抵抗:理解更好治疗 2 型糖尿病的机制。
Curr Diabetes Rev. 2024;21(1):e170124225723. doi: 10.2174/0115733998281910231231051814.
9
Deletion of gene causes early growth retardation and insulin resistance in mice.基因缺失导致小鼠生长早期迟缓及胰岛素抵抗。
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2213628119. doi: 10.1073/pnas.2213628119. Epub 2022 Nov 28.
10
Ameliorative effects of high intensity interval training and against tetracycline-induced fatty liver in rats: a gene expression profiling comparative study.高强度间歇训练对大鼠四环素诱导性脂肪肝的改善作用:一项基因表达谱比较研究
EXCLI J. 2022 Jul 21;21:991-1006. doi: 10.17179/excli2022-4791. eCollection 2022.
2 型糖尿病男性的基础状态和胰岛素介导的 VLDL-甘油三酯动力学。
Diabetes. 2011 Jan;60(1):88-96. doi: 10.2337/db10-0564. Epub 2010 Sep 21.
4
Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.乳糜微粒和 VLDL 衍生的脂质通过不同途径进入心脏:体内脂肪酸摄取的受体和非受体介导的证据。
J Biol Chem. 2010 Dec 3;285(49):37976-86. doi: 10.1074/jbc.M110.174458. Epub 2010 Sep 18.
5
Apolipoprotein CIII induces monocyte chemoattractant protein-1 and interleukin 6 expression via Toll-like receptor 2 pathway in mouse adipocytes.载脂蛋白 CIII 通过 Toll 样受体 2 通路诱导小鼠脂肪细胞中单核细胞趋化蛋白-1 和白细胞介素 6 的表达。
Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2242-8. doi: 10.1161/ATVBAHA.110.210427. Epub 2010 Sep 9.
6
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.载脂蛋白 C3 基因变异与非酒精性脂肪性肝病。
N Engl J Med. 2010 Mar 25;362(12):1082-9. doi: 10.1056/NEJMoa0907295.
7
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.膳食胆固醇可诱导肝脏单核细胞趋化蛋白-1 上调并促进肝脏脂肪变性。
Cytokine. 2009 Dec;48(3):273-9. doi: 10.1016/j.cyto.2009.08.006. Epub 2009 Sep 12.
8
Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions.载脂蛋白 C-III 在 McA-RH7777 细胞中的表达增强了富含脂质条件下 VLDL 的组装和分泌。
J Lipid Res. 2010 Jan;51(1):150-61. doi: 10.1194/M900346-JLR200.
9
Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets.动脉粥样硬化小鼠在血管外膜和内脏脂肪组织、肝脏和胰岛中表现出全身炎症。
Atherosclerosis. 2009 Dec;207(2):360-7. doi: 10.1016/j.atherosclerosis.2009.05.004. Epub 2009 May 14.
10
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.人类载脂蛋白C3(APOC3)的无效突变可带来良好的血脂谱并具有明显的心脏保护作用。
Science. 2008 Dec 12;322(5908):1702-5. doi: 10.1126/science.1161524.